The EUP OHAMR will consist of 51 organisations from 28 countries that together with the EC will commit over 340 MEUR over 10 years to boost One Health AMR R&I in all its dimensions: coordinating joint transnational calls, actions to strengthen the capacity of the AMR research community, provide frameworks for alignment of policy and stakeholder engagement, and tools to valorise the new knowledge for the benefit of citizens and society as a whole.
Thank you to all partners for your cooporation and support to develop the proposal!
Updated EUP OHAMR
Strategic Research and Innovation Agenda
The strategic foundation of the EUP OHAMR is outlined in the Strategic Research and Innovation Agenda (SRIA), which covers research on bacteria, viruses, fungi, and parasites and resistance in pathogens that are transmitted among humans or between animals and humans, and present in the environment including wildlife having consequences on human health.
A first draft of the EUP OHAMR SRIA was published in May 2023 and the current updated version was published in September 2024.
New GRAM study on the global burden of antimicrobial resistance
Resistance to antibiotics led to at least one million deaths each year since 1990, with increasing rates of drug-resistant infections expected to claim more than 39 million lives between now and 2050 without further action, according to a landmark study by the Global Research on Antimicrobial Resistance (GRAM) Project.
UN General Assembly (UNGA) High-Level Meeting on AMR
The UNGA High-Level Meeting on AMR was held in New York on September 26th, and global leaders approved the political declaration outlining targets and ambitions across six areas: Governance, Financing, Access, Coordinated multisectoral response (in human health, agriculture and animal health, and the environment), Research and development, training, innovation and manufacturing, and Surveillance and monitoring.
JPIAMR supported research networks developing international AMR benchmarking standards
The JPIAMR
networks B2B2B AMR Dx and Seq4AMR are working on use of different workflows to
generate antimicrobial resistance (AMR) gene lists and AMR phenotype from
identical bacterial whole genome sequencing (WGS) data and developing
benchmarking in WGS-AMR prediction and the BenchAMRking
platform.
The pilot BenchAMRking application is only the start of the process towards international
standardisation and capacity building, networking and collaboration in this
field, thereby requiring the input and enthusiasm from stakeholders interested
in this field of research.
